|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/07/21 Ingredion Inc. 10-Q 3/31/21 86:11M Toppan Merrill Bridge/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 1.25M
2: EX-10.2 Material Contract HTML 121K
3: EX-10.3 Material Contract HTML 112K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 28K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 29K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 24K
7: EX-32.2 Certification -- §906 - SOA'02 HTML 24K
14: R1 Document and Entity Information HTML 75K
15: R2 Condensed Consolidated Statements of (Loss) Income HTML 96K
16: R3 Condensed Consolidated Statements of Comprehensive HTML 52K
(Loss)
17: R4 Condensed Consolidated Statements of Comprehensive HTML 27K
(Loss) (Parenthetical)
18: R5 Condensed Consolidated Balance Sheet HTML 130K
19: R6 Condensed Consolidated Balance Sheet HTML 42K
(Parenthetical)
20: R7 Condensed Consolidated Statements of Equity HTML 51K
21: R8 Condensed Consolidated Statement of Redeemable HTML 36K
Equity
22: R9 Condensed Consolidated Statements of Cash Flows HTML 91K
23: R10 Interim Financial Statements HTML 27K
24: R11 Summary of Significant Accounting Policies HTML 32K
25: R12 Acquisitions HTML 45K
26: R13 Revenue Recognition HTML 52K
27: R14 Restructuring and Impairment Charges HTML 63K
28: R15 Financial Instruments, Derivatives and Hedging HTML 238K
Activities
29: R16 Debt HTML 57K
30: R17 Leases HTML 87K
31: R18 Taxes HTML 29K
32: R19 Net Periodic Pension and Postretirement Benefit HTML 71K
Costs
33: R20 Inventories HTML 38K
34: R21 Equity HTML 427K
35: R22 Segment Information HTML 93K
36: R23 Subsequent Events HTML 26K
37: R24 Acquisitions (Tables) HTML 38K
38: R25 Revenue Recognition (Tables) HTML 42K
39: R26 Restructuring and Impairment Charges (Tables) HTML 55K
40: R27 Financial Instruments, Derivatives and Hedging HTML 253K
Activities (Tables)
41: R28 Debt (Tables) HTML 53K
42: R29 Leases (Tables) HTML 86K
43: R30 Net Periodic Pension and Postretirement Benefit HTML 69K
Costs (Tables)
44: R31 Inventories (Tables) HTML 38K
45: R32 Equity (Tables) HTML 426K
46: R33 Segment Information (Tables) HTML 88K
47: R34 Acquisitions - PureCircle (Details) HTML 64K
48: R35 Acquisitions - Verdient (Details) HTML 39K
49: R36 Acquisitions - Integration costs (Details) HTML 26K
50: R37 Revenue Recognition (Details) HTML 41K
51: R38 Restructuring and Impairment Charges - Charges HTML 37K
(Details)
52: R39 Restructuring and Impairment Charges - Impairment HTML 44K
Charges (Details)
53: R40 Restructuring and Impairment Charges - Assets and HTML 80K
liabilities classified as held-for-sale (Details)
54: R41 Restructuring and Impairment Charges - Other HTML 56K
Charges (Details)
55: R42 Restructuring and Impairment Charges - HTML 35K
Employee-related severance (Details)
56: R43 Financial Instruments, Derivatives and Hedging HTML 36K
Activities - Commodity price hedging (Details)
57: R44 Financial Instruments, Derivatives and Hedging HTML 35K
Activities - Foreign currency hedging (Details)
58: R45 Financial Instruments, Derivatives and Hedging HTML 31K
Activities - Interest rate hedging (Details)
59: R46 Financial Instruments, Derivatives and Hedging HTML 39K
Activities - CF Hedges in AOCI (Details)
60: R47 Financial Instruments, Derivatives and Hedging HTML 71K
Activities - Balance Sheet Location (Details)
61: R48 Financial Instruments, Derivatives and Hedging HTML 41K
Activities - Additional information - CF hedges
(Details)
62: R49 Financial Instruments, Derivatives and Hedging HTML 35K
Activities - Gain (Losses) Recognized in Income
(Details)
63: R50 Financial Instruments, Derivatives and Hedging HTML 44K
Activities - FV (Details)
64: R51 Debt - Components (Details) HTML 54K
65: R52 Leases - Lease costs (Details) HTML 35K
66: R53 Leases - Operating lease reconciliation (Details) HTML 48K
67: R54 Leases - Other Information (Details) HTML 32K
68: R55 Taxes - Effective tax rate (Details) HTML 28K
69: R56 Net Periodic Pension and Postretirement Benefit HTML 61K
Costs (Details)
70: R57 Inventories (Details) HTML 32K
71: R58 Equity - Treasury stock (Details) HTML 34K
72: R59 Equity - Share-based payments (Details) HTML 37K
73: R60 Equity - Stock options (Details) HTML 97K
74: R61 Equity - Restricted stock units (Details) HTML 65K
75: R62 Equity - Performance shares (Details) HTML 76K
76: R63 Equity - AOCL (Details) HTML 50K
77: R64 Equity - Statements of Equity with dividends per HTML 61K
share (Details)
78: R65 Equity - Statements of Redeemable Equity (Details) HTML 35K
79: R66 Equity - EPS (Details) HTML 58K
80: R67 Segment Information - Net sales (Details) HTML 57K
81: R68 Segment Information - Assets (Details) HTML 35K
82: R69 Subsequent Events (Details) HTML 32K
84: XML IDEA XML File -- Filing Summary XML 151K
13: XML XBRL Instance -- ingr-20210331x10q_htm XML 3.12M
83: EXCEL IDEA Workbook of Financial Reports XLSX 93K
9: EX-101.CAL XBRL Calculations -- ingr-20210331_cal XML 193K
10: EX-101.DEF XBRL Definitions -- ingr-20210331_def XML 668K
11: EX-101.LAB XBRL Labels -- ingr-20210331_lab XML 1.43M
12: EX-101.PRE XBRL Presentations -- ingr-20210331_pre XML 1.09M
8: EX-101.SCH XBRL Schema -- ingr-20210331 XSD 171K
85: JSON XBRL Instance as JSON Data -- MetaLinks 415± 614K
86: ZIP XBRL Zipped Folder -- 0001558370-21-006479-xbrl Zip 305K
EXHIBIT 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
I, James D. Gray, certify that:
| 1. | I have reviewed this quarterly report on Form 10-Q of Ingredion Incorporated; |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
| 4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
| (a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
| (b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
| (c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
| (d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
| 5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
| (a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
| (b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
6 | |
Date: May 7, 2021 | /s/ James D. Gray |
| |
| Executive Vice President and Chief Financial Officer |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 5/7/21 | 4 | ||
| For Period end: | 3/31/21 | 4 | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/21/23 Ingredion Inc. 10-K 12/31/22 141:70M 2/22/22 Ingredion Inc. 10-K 12/31/21 131:21M Toppan Merrill Bridge/FA 5/27/21 Ingredion Inc. S-8 5/27/21 3:76K Donnelley … Solutions/FA |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/18/21 Ingredion Inc. 8-K:1,9 3/16/21 11:683K Donnelley … Solutions/FA |